53959 Treatment With Upadacitinib Increases the Achievement of Minimal Disease Activity Among Patients With Moderate-to-Severe Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1 and Measure Up 2) - 02/09/24
Doi : 10.1016/j.jaad.2024.07.379
Jonathan I. Silverberg, MD, PhD, MPH
Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington DC, United States
Melinda J. Gooderham, MD
SKiN Centre for Dermatology, Peterborough, Ontario, Canada
3Probity Medical Research, Peterborough, Ontario, Canada
Division of Dermatology, Queen’s University, Kingston, Ontario, Canada
Norito Katoh, MD, PhD
Department of Dermatology Kyoto Prefectural University of Medicine, Kyoto, Japan
Valeria Aoki, MD, PhD
Department of Dermatology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
Andrew E. Pink, PhD
St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK
Yousef Binamer, MD
Department of Dermatology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
9College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
10 AbbVie Inc., North Chicago, Illinois, United States
Andreas Wollenberg, MD
Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
Department of Dermatology and Allergy, University Hospital Augsburg, Augsburg, Germany
Le texte complet de cet article est disponible en PDF.
| Commercial Support: AbbVie Inc. funded this study and participated in the study design, study research, collection, analysis, and interpretation of data, and writing, reviewing, and approving this abstract for submission. All authors had access to relevant data and participa. |
© 2024
Publié par Elsevier Masson SAS.
Vol 91 - N° 3S
P. AB94 - septembre 2024 Retour au numéro
Article précédent
- 53899 Treatment success with sarecycline for treatment of acne vulgaris (AV): Comparison of results from randomized controlled trials (RCTs) and the real-world (RW) PROSES study
- Emmy Graber, James Del Rosso, Ismail Kasujee, Raidah Salem, Paul Tomondy, Hilary Baldwin
- 54563 Trends in surgical management of hidradenitis suppurativa in the Medicare population
- Zachary Wendland, Katelyn Rypka, Ziou Jiang, Joslyn Kirby, Christopher Sayed, Noah Goldfarb
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?